| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |